CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist

77.09
+1.80+2.39%

Market Closed Mar 18 15:00 CST

6.11BMarket Cap22.10P/E (TTM)

Hangzhou Alltest Biotech Stock Forum

Moomoo AI

Mar 1, 2024 07:35

Hangzhou Alltest Biotech's low ROE and net income growth are worrisome. Despite profit retention, the low ROE indicates that investors may not be reaping benefits. The company's growth lags behind industry average, raising concerns. Future earnings growth and its effect on stock price need assessment.